Transcript presentation

EYEDIFF PLUS +3.50D
Diffractive Multifocal IOL
“A New Alternative”
Prof. Dr. Daniel H. Scorsetti
University of the Salvador - Catholic Pontificia University of Argentina
Faculty of Medicine - Faculty of Medical Sciences
Chair of Ophthalmology
Buenos Aires, Argentina
Eyediff Plus +3.50D: Technical Specifications
EYEDIFF Plus Presbyopic IOL
 Diffractive Technology
 Perfect Light Distribution for Distance &Near( 60/40)
 Addresses Cataract Patients with or without Presbyopia
 Allowed Patients a High Level of Freedom From Glasses in
clinical trial
Full Optic Regular Diffractive IOL
Advantages

Provides multifocal vision

Reduced pupil dependency

Balanced distribution of light

Able to tolerate some decentration
Full Optic Diffractive IOL





Advantages
Provides multifocal vision
Reduced pupil dependency
Balanced distribution of light
Able to tolerate some decentration
 * Creates Halos and scattering Light
Disadvantages
 Potential for Scattering of light
and glare and halos at night
but
Zones
EYEDIFF Plus - Predictable refractive outcome
+3.00D Addition
EYEDIFF Plus - Predictable refractive outcome
+3.50D Addition
EYEDIFF Plus - Predictable refractive outcome
+4.00D Addition
Show Optic
Far
Intermediate
Near
EYEDIFF PLUS – Predictable Customized LIO
EYEDIFF PLUS - Predictable refractive outcome
Analysis of the mistake : Square root of the sum of the squares
Warren E. Hill, MD, FACS
EYEDIFF PLUS - Predictable refractive outcome
Analysis of the mistake : Square root of the sum of the squares
Warren E. Hill, MD, FACS
Aspheric Optic (Aberration Neutral)
360° Square Edge
EYEDIFF Plus 360⁰Square Edge
 Edge thickness correspond to
standard designed IOLs
 Square edge design
 Perfect centration in the capsular bag
 Perfect optical performance
 Extremely low incidence of PCO
 Anti Z effect Haptic design
IOL Power calculation
 Careful Keratometry
1.0D corneal power error affects 1.3 to 1.6D IOL
power calculation
 Careful Axial Length
1.0mmAL error affects the post-operative refraction
by 1.2 to 2.5D aprox.
 IOL Master: SRK II--------- 118.6
SRK T-------- 118.4
Holladay 1 - sf--- 1.37
Haigis ----- a0=0.95, a1=0.4, a2=0.10
Hofer - pACD-- 5.17
 Aim Emmetropia & Astigmatism <1.0D
 A-Const. & ACD ( Surgeon Factors)
Clinical Trial
 Objective: to compare the visual quality preop and postop., between
2 multifocal IOLs and 1 monofocal
 Material and methods : 60 eyes of 30 pts. divided into 3 groups,
informed and signed assent, cataract degrees II and III, older than 55
years (average 60 years), without ocular disease or astigmatism > 1.0D.
Bilateral implants, the same IOL in every patient (not mix and match)
 Equipment: Alcon Infinity
Technique : Facotorsional with Ozil IP, 2.2mm (intrepid)
Incision in the steepest axis and the same protocol in all cases
• Group 1: 10 pts.
Acrysoft IQ
• Group 2: 10 pts.
Acrysoft Restor
• Group 3: 10 pts.
EYEDIFF PLUS +3.5D
Clinical Trial
 Preop Complete ocular exam:
•
•
•
•
•
UCVA & BCVA: far, intermediate (70 cm) and near (40 cm)
Pentacam HR
IOL Master
Contrast Sensibility : photopic and mesopic
NEI VFQ-25 Questionnaire with Apéndix NEI VFQ-39 (in Spanish)
 6 questions to evaluate visual general health
 20 questions to evaluate difficulties in visual activities
 13 questions to evaluate level of acceptance of visual loss
NEI VFQ: National Eye Institute, Visual Function Questionnaire
Clinical Trial
 Postop complete examination : days 1 - 7- 30 - 90
• UCVA & BCVA: far, intermediate (70 cm) and near (40 cm)
• Pentacam HR
• Contrast Sensibility : photopic and mesopic
• NEI VFQ-25 Questionnaire with Apéndix NEI VFQ-39 (in Spanish)
 6 questions to evaluate visual general health
 20 questions to evaluate difficulties in visual activities
 13 questions to evaluate level of acceptance of visual loss
• Follow-up 3 months
Results
 Questionnaire
• Group 2 and 3: better in postop. to read newspaper and close
vision activities.
• Group 3: less difficulty in night driving, But without statistically
significant difference with 2.
• Group1: statistical significant difference to favor to drive by night
 Without intraop complications
 Without PCO
 Descentrations
• 2 minor in group 2
• 1 minor in group 3
 Halos/Glare
• 3 tolerable in group 2
• 2 tolerable in group 3
Results FAR – GROUP 1: Acrysoft IQ
UCVA
BCVA
0.89
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.75
0.58
0.17
Preop
1 Week 1 Month
3
PO.
PO.
Months
PO.
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.95
1
0.79
0.51
Preop 1 Week 1 Month
3
PO.
PO. Months
PO.
Results FAR – GROUP 2: Acrysoft Restor
UCVA
BCVA
0.91
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.81
0.65
0.18
Preop
1 Week 1 Month
3
PO.
PO.
Months
PO.
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.93
1
0.71
0.55
Preop 1 Week 1 Month
3
PO.
PO. Months
PO.
Results FAR – GROUP 3: EYEDIFF PLUS
UCVA
BCVA
0.91
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.94
0.71
0.23
Preop
1 Week 1 Month
3
PO.
PO.
Months
PO.
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.99
1
0.76
0.42
Preop 1 Week 1 Month
3
PO.
PO. Months
PO.
Results NEAR – GROUP 2: Acrysoft Restor
UCVA
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
BCVA
0.93
0.95
0.79
0.28
Preop
1 Week 1 Month
3
PO.
PO.
Months
PO.
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.92
1
1
0.51
Preop 1 Week 1 Month
3
PO.
PO. Months
PO.
Results NEAR – GROUP 3: EYEDIFF PLUS
AV S/C
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.83
AV C/C
0.96
0.73
0.32
Preop
1 Week 1 Month
3
PO.
PO.
Months
PO.
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0.89
0.95
1
0.62
Preop 1 Week 1 Month
3
PO.
PO. Months
PO.
Intermediate Vision (70 cm)
GROUP 2
Acrysof Restor
INTERMEDIATE
WITHOUT CORRECTION
INTERMEDIATE WITH
CORRECTION
GROUP 3 –
EYEDIFF PLUS
INTERMEDIATE
WITHOUT CORRECTION
INTERMEDIATE WITH
CORRECTION
DECIMAL
DISTANCE
0.4
70 cm
1.0
70 cm
DECIMAL
DISTANCE
0.5
70 cm
1.0
70 cm
EYEDIFF Plus
EYEDIFF Plus
Conclusions
 Less adverse effects
 Good results post-surgery
 Individual map with MTF and topography of
IOL power
 Variety of powers for near
 First Customized IOL
 Cost
Thank you very much!!!
[email protected]